Dergiler / Turkish Journal of Chemistry / 2018 / Cilt: 42 - Sayı: 2

$Nickel(II)-PPh_3$ complexes with ONS and ONN chelating thiosemicarbazones: synthesis and inhibition potential on influenza A viruses

Sayfa
371–384
Yayın Tarihi
2022-11-05
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The effects of the compounds on the influenza virus and structure–antiviral activity relationships were discussed based on the donor atoms and S-alkyl substituents.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Tetra-coordinated nickel(II) complexes of two ONS (1, 2) and seven ONN (3a–3g) chelating 2-hydroxy3-methoxy-benzaldehyde thiosemicarbazones were synthesized.
📊
Temel Bulgular & Veri:The dibasic ligands and complexes bearing PPh 3 as a coligand were characterized by means of analytical and spectroscopic data.
💡
Sonuç & Katkı:The effects of the compounds on the influenza virus and structure–antiviral activity relationships were discussed based on the donor atoms and S-alkyl substituents.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Tetra-coordinated nickel(II) complexes of two ONS (1, 2) and seven ONN (3a–3g) chelating 2-hydroxy3-methoxy-benzaldehyde thiosemicarbazones were synthesized. The dibasic ligands and complexes bearing PPh 3 as a coligand were characterized by means of analytical and spectroscopic data. Cytotoxic activities of the ligands and nickel(II) complexes were determined using the MTT assay in vitro against MDCK cells, and then all the compounds were tested on influenza virus replication by plaque assays. The compounds showed $GI_{50}$ values varying from concentrations of 15.9 up to 161.8 µ g/mL for MDCK cells. The plaque assays indicated that one ONS (1) and two ONN (3c and 3d) chelate structures have considerable antiviral effects on influenza A viruses at lower concentrations than the $GI_{50}$ values for MDCK cells. The ligands and other complexes did not show any inhibitory effects on influenza virus plaque formation. The effects of the compounds on the influenza virus and structure–antiviral activity relationships were discussed based on the donor atoms and S-alkyl substituents.

🔖

Bu Makaleye Atıf Yap

GÜVELİ, Ş., TURAN, K., ÜLKÜSEVEN, B. (2022). $Nickel(II)-PPh_3$ complexes with ONS and ONN chelating thiosemicarbazones: synthesis and inhibition potential on influenza A viruses. Turkish Journal of Chemistry, Cilt: 42 - Sayı: 2, 371–384. https://ajindex.com/articles/601782

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (22)

  1. Oxford, J. S. Rev. Med. Virol. 2000, 10, 119-133
  2. Yoon, S. W.; Webby, R. J.; Webster, R. G. Curr. Top. Microbiol. Immunol. 2014, 385, 359-375
  3. Eagles, D.; Siregar, E. S.; Dung, D. H.; Weaver, J.; Wong, F.; Daniels, P. Rev. Sci. Tech. 2009, 28, 341-348
  4. Gilbert, M.; Xiao, X.; Pfeiffer, D. U.; Epprecht, M.; Boles, S.; Czarnecki, C.; Chaitaweesub, P.; Kalpravidh, W.; Minh, P. Q.; Otte, M. J. et al. P. Natl. Acad. Sci. USA 2008, 105, 4769-4774
  5. Jimenez-Alberto, A.; Alvarado-Facundo, E.; Ribas-Aparicio, R. M.; Castelan-Vega, J. A. PLoS One 2013, 8, e70005
  6. Laver, W. G. Microbiol. Sci. 1984, 1, 37-43
  7. Govorkova, E. A.; Gambaryan, A. S.; Claas, E. C.; Smirnov, Y. A. Acta Virol. 2000, 44, 241-248
  8. Intharathep, P.; Laohpongspaisan, C.; Rungrotmongkol, T.; Loisruangsin, A.; Malaisree, M.; Decha, P.; Aruksakunwong, O.; Chuenpennit, K.; Kaiyawet, N.; Sompornpisut, P. et al. J. Mol. Graph. Model. 2008, 27, 342-348
  9. De Clercq, E. J. Clin. Virol. 2004, 30, 115-133
  10. Hussain, M; Galvin, H. D.; Haw, T. Y.; Nutsford, A. N.; Husain, M. Infect. Drug Resist. 2017, 20, 121-134
  11. Gamblin, S. J.; Skehel, J. J. J. Biol. Chem. 2010, 285, 28403-28409
  12. Tong, S.; Zhu, X.; Li, Y.; Shi, M.; Zhang, J. et al. PLoS Pathog. 2013, 9, e1003657
  13. Takemoto, D. K.; Skehel, J. J.; Wiley, D. C. Virology 1996, 217, 452-458
  14. Hidari, K. I; Yamaguchi, M.; Ueno, F.; Abe, T.; Yoshida, K.; Suzuki, T. Biochem. Biophys. Res. Commun. 2013, 436, 394-399
  15. Palese, P.; Tobita, K.; Ueda, M.; Compans, R. W. Virology 1974, 61, 397-410
  16. Liu, C.; Eichelberger, M. C.; Compans, R. W.; Air, G. M. J. Virol. 1995, 69, 1099-1106
  17. Cohen, M.; Zhang, X. Q.; Senaati, H. P.; Chen, H. W.; Varki, N. M.; Schooley, R. T.; Gagneux, P. Virol. J. 2013, 10, 321
  18. Shinya, K.; Fujii, Y.; Ito, H.; Ito, T.; Kawaoka, Y. J. Virol. 2004, 78, 3083-3088
  19. Kim, C. U.; Lew, W.; Williams, M. A.; Liu, H.; Zhang. L.; Swaminathan, S.; Bischofberger, N.; Chen, M. S.; Mendel, D. B.; Tai, C. Y. et al. J. Am. Chem. Soc. 1997, 119, 681-690
  20. Michiels, B.; Van Puyenbroeck, K.; Verhoeven, V.; Vermeire, E.; Coenen, S. PLoS One 2013, 8, e60348
  21. Takashita, E.; Fujisaki, S.; Kishida, N.; Xu, H.; Imai, M.; Tashiro, M.; Odagiri, T.; Influenza Virus Surveillance Group of Japan. Influenza Other Resp. 2013, 7, 1390-1399
  22. Monto, A. S.; McKimm-Breschkin, J. L.; Macken, C.; Hampson, A. W.; Hay, A.; Klimov, A.; Tashiro, M.; Webster, R. G.; Aymard, M.; Hayden, F. G. et al. Antimicrob. Agents Chemot